1,678
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Quality assessment of positron emission tomography scans: recommendations for future multicentre trials

ORCID Icon, , , , , , & show all
Pages 1459-1464 | Received 01 May 2017, Accepted 20 May 2017, Published online: 22 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jens Overgaard, Ludvig Paul Muren, Morten Høyer & Cai Grau. (2019) BIGART 2019 – adapting to the future. Acta Oncologica 58:10, pages 1323-1327.
Read now

Articles from other publishers (9)

Daniela Thorwarth. (2023) Clinical use of positron emission tomography for radiotherapy planning – Medical physics considerations. Zeitschrift für Medizinische Physik 33:1, pages 13-21.
Crossref
Poul F. Høilund-Carlsen, Reza Piri, Oke Gerke, Michael Sturek, Thomas J. Werner, Mona-Elisabeth Revheim & Abass Alavi. (2023) NaF-PET Imaging of Atherosclerosis Burden. Journal of Imaging 9:2, pages 31.
Crossref
Ran Klein, Mike Oliver, Dan La Russa, John Agapito, Stewart Gaede, JeanPierre Bissonnette, Arman Rahmim & Carlos Uribe. (2022) COMP Report: CPQR technical quality control guidelines for use of positron emission tomography/computed tomography in radiation treatment planning. Journal of Applied Clinical Medical Physics 23:12.
Crossref
Freimut D. Juengling, Frank Wuest, Sanjay Kalra, Federica Agosta, Ralf Schirrmacher, Alexander Thiel, Wolfgang Thaiss, Hans-Peter Müller & Jan Kassubek. (2022) Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease—A clinico-radiological and neuroscientific perspective. Frontiers in Neurology 13.
Crossref
Relinde I. Y. Lieverse, Evert J. Van Limbergen, Cary J. G. Oberije, Esther G. C. Troost, Sine R. Hadrup, Anne-Marie C. Dingemans, Lizza E. L. Hendriks, Franziska Eckert, Crispin Hiley, Christophe Dooms, Yolande Lievens, Monique C. de Jong, Johan Bussink, Xavier Geets, Vincenzo Valentini, Giuliano Elia, Dario Neri, Charlotte Billiet, Amir Abdollahi, David Pasquier, Pierre Boisselier, Ala Yaromina, Dirk De Ruysscher, Ludwig J. Dubois & Philippe Lambin. (2020) Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial. BMC Cancer 20:1.
Crossref
Tom Konert, Sarah Everitt, Matthew D. La Fontaine, Jeroen B. van de Kamer, Michael P. MacManus, Wouter V. Vogel, Jason Callahan & Jan-Jakob Sonke. (2020) Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?. PLOS ONE 15:2, pages e0228793.
Crossref
Janna E. van Timmeren, Sara Carvalho, Ralph T. H. Leijenaar, Esther G. C. Troost, Wouter van Elmpt, Dirk de Ruysscher, Jean-Pierre Muratet, Fabrice Denis, Tanja Schimek-Jasch, Ursula Nestle, Arthur Jochems, Henry C. Woodruff, Cary Oberije & Philippe Lambin. (2019) Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics. PLOS ONE 14:6, pages e0217536.
Crossref
Simon A Keek, Ralph TH Leijenaar, Arthur Jochems & Henry C Woodruff. (2018) A review on radiomics and the future of theranostics for patient selection in precision medicine. The British Journal of Radiology 91:1091, pages 20170926.
Crossref
Evelyn E.C. de Jong, Lizza E.L. Hendriks, Wouter van Elmpt, Hester A. Gietema, Paul A.M. Hofman, Dirk K.M. De Ruysscher & Anne-Marie C. Dingemans. (2018) What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer. Lung Cancer 123, pages 112-115.
Crossref